ILMN vs ZNTL · rev $4.34B vs $257.7M cap
Illumina Inc (ILMN) versus Zentalis Pharmaceuticals Llc (ZNTL) — a side-by-side from cached financials, not a winner call.
Illumina Inc (ILMN) is a diagnostics & research company listed on US. It is led by Jacob Thaysen Ph.D..
Zentalis Pharmaceuticals Llc (ZNTL) is a biotechnology company listed on NASDAQ.
Latest reported ILMN revenue for 2025-12-28 was $4.34B. Net income was $850.0M. ILMN currently screens at market cap $15.84B.
Latest reported ZNTL revenue for 2025-09-30 was $0. Net income was -$26.7M. ZNTL currently screens at market cap $257.7M.
ILMN currently screens at market cap $15.84B. ZNTL currently screens at market cap $257.7M.
Not investment advice. Open the ILMN and ZNTL stock pages for the full models.
Not investment advice.